This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Alberta directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
Journal of psychopharmacology (Oxford, England) · 2021 · senior author
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
BMC medicine · 2020
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.
Therapeutic advances in psychopharmacology · 2020
Latest funding
The health effects of the Alberta wildfire and evacuation: Pediatric resiliency
CIHR · 2016 · Principal investigator
- $1,750,000
Prairie CRISM Node Proposal
CIHR · 2014 · Co-investigator
- $99,900
Diagnostics and Prognostics for Alzheimer's Disease and Related Dementias: Machine Learning Analysis of Existing Neuroimaging Datasets
CIHR · 2012 · Nominated PI
14 publications.
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.
Dos Santos RG, Hallak JE, Baker G, Dursun S
Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C
Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches.
Ostuzzi G, Gastaldon C, Papola D, Fagiolini A, Dursun S, Taylor D, Correll CU, Barbui C
Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations.
Ostuzzi G, Papola D, Gastaldon C, Schoretsanitis G, Bertolini F, Amaddeo F, Cuomo A, Emsley R, Fagiolini A, Imperadore G, Kishimoto T, Michencigh G, Nosé M, Purgato M, Dursun S, Stubbs B, Taylor D, Thornicroft G, Ward PB, Hiemke C, Correll CU, Barbui C
Adapting to the impact of COVID-19 on mental health: an international perspective.
Thomas RK, Suleman R, Mackay M, Hayer L, Singh M, Correll CU, Dursun S
Esketamine for treatment resistant depression.
Swainson J, Thomas RK, Archer S, Chrenek C, MacKay MA, Baker G, Dursun S, Klassen LJ, Chokka P, Demas ML
Rapid effectiveness of intravenous ketamine for ultraresistant depression in a clinical setting and evidence for baseline anhedonia and bipolarity as clinical predictors of effectiveness.
Thomas RK, Baker G, Lind J, Dursun S
Treating electroconvulsive therapy-induced mania with more electroconvulsive therapy: Evidence for electroconvulsive therapy as the ultra-mood stabilizer.
Thomas RK, White PJ, Dursun S
Methylene blue treatment for residual symptoms of bipolar disorder: Randomised crossover study
Alda M, McKinnon M, Blagdon R, Garnham J, MacLellan S, O'Donovan C, Hajek T, Nair C, Dursun S, MacQueen G
An investigation into aripiprazole's partial D₂ agonist effects within the dorsolateral prefrontal cortex during working memory in healthy volunteers.
Murphy A, Dursun S, McKie S, Elliott R, Deakin JF
The health effects of the Alberta wildfire and evacuation: Pediatric resiliency
Principal investigators: Silverstone, Peter H; Corbett, Sandra; Franc, Jeffrey M; Shand, Tom; Agyapong, Vincent O; Drolet, Julie; Dursun, Serdar M; McDonald-Harker, Caroline B
Keywords: Adolescents; Children; Disaster Recovery; Population Mental Health; Psychiatry; Psycho-Social Care; Resiliency; Wildfire
Prairie CRISM Node Proposal
Principal investigators: Wild, Cameron T; Aubry, Allan; Dell, Colleen A; Hodgins, David C
Keywords: Client Motivation; Knowledge Exchange; Prevention; Screening And Brief Interventions; Substance Misuse; Treatment
Diagnostics and Prognostics for Alzheimer's Disease and Related Dementias: Machine Learning Analysis of Existing Neuroimaging Datasets
Principal investigators: Dursun, Serdar M; Greiner, Russ
Keywords: Alzheimer'S; Biomarkers; Dementia; Diagnosis; Machine Learning; Magnetic Resonance Imaging; Metabolomics; Neuroimaging; Positron Emission Tomography; Prognosis
Translational neuroimaging in alcoholism: identification of altered brain connectivity and treatment efficacy predictors
Principal investigators: Dursun, Serdar M; Hyytia, Petri; Mann, Karl; Santiago, Canals; Sommer, Wolfgang
Keywords: Alcoholism; Translational Neuroimaging
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Psychiatry
- Pediatrics
- Occupational Therapy
- Psychiatry & Behavioural Neurosciences
Co-authors at University of Alberta, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Lisa Hartling
Pediatrics
1 shared papers, latest 2012
Liana Urichuk
Pediatrics
1 shared papers, latest 2008
Tomas Hajek
Psychiatry
1 shared papers, latest 2017
Andrew Greenshaw
Occupational Therapy
1 shared papers, latest 2015
Margaret McKinnon
Psychiatry & Behavioural Neurosciences
1 shared papers, latest 2017
Martin Alda
Psychiatry
1 shared papers, latest 2017
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.